What Has Been the Growth Trajectory for the Acute Pancreatitis Market in Recent Years?
The acute pancreatitis market has seen considerable growth due to a variety of factors.
•The market for acute pancreatitis has expanded significantly in the last few years. The market, which is set to increase from $5.96 billion in 2024 to $6.31 billion in 2025, will have a compound annual growth rate (CAGR) of 5.9%.
The reason for this growth in the past years can be attributed to high occurrence rates, patterns of alcohol intake, the commonness of gallstones, tobacco smoking trends, and rising obesity percentages.
How Does the Forecast Look for the Acute Pancreatitis Market?
The acute pancreatitis market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations suggest that the acute pancreatitis market will experience substantial expansion in the subsequent years, reaching "$8.04 billion in 2029 with a compound annual growth rate (CAGR) of 6.2%.
The anticipated expansion during the forecast period can be credited to factors such as an increase in the aged population, awareness campaigns and early detection programs, genetic susceptibility research, and innovation in treatment methods. Noteworthy trends for the period include enhancing nutritional support, patient information and awareness drives, the enforcement of standardized procedures, exploration of cell-reviving therapies, alongside continuous monitoring and assessment.
What Are The Leading Drivers Of Growth In The Acute Pancreatitis Market?
The surge in spending on healthcare is anticipated to fuel the expansion of the acute pancreatitis market in the future. The term healthcare expenditure pertains to all resources, both monetary and non-monetary, expended on providing health services and related activities. Several factors contribute to the rise in healthcare costs, including the high prevalence of chronic ailments, the broadening scope of health insurance, and heightened awareness of mental health problems. Acute pancreatitis can result in serious complications like necrotizing pancreatitis, organ failure, and infections, demanding supplemental treatments, surgeries, and extended hospital stays, thereby significantly increasing healthcare expenses. As an illustration, data from the Canadian Institute for Health Information, a non-profit organization based in Canada, predicts that total health spending will touch $344 billion in 2023, displaying modest growth of 2.8% from the preceding year. Consequently, the rising expenditure on healthcare is stimulating the expansion of the acute pancreatitis market.
How Are The Segments Defined Within The Global Acute Pancreatitis Market?
The acute pancreatitis market covered in this report is segmented –
1) By Cause: Gallstones, Alcohol, Other Causes
2) By Treatment: Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments
3) By Diagnosis: Imaging tests, Laboratory Tests
4) By End Users: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Gallstones: Cholecystitis-Induced Pancreatitis, Choledocholithiasis-Induced Pancreatitis
2) By Alcohol: Acute Alcoholic Pancreatitis, Binge Drinking-Induced Pancreatitis
3) By Other Causes: Medications-Induced Pancreatitis, Trauma-Induced Pancreatitis, Infections-Induced Pancreatitis, Metabolic Disorders
Pre-Book The Acute Pancreatitis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Acute Pancreatitis Market?
Leading businesses in the acute pancreatitis market are pioneering advancements in technologies such as dry chemistry slide technology that precisely determine pancreatic lipase levels. The dry chemistry slide technology is a diagnostic tool that leverages a slide coated in dry reagents to execute chemical reactions for biological sample analysis, thereby permitting swift and accurate testing without using liquid reagents. In June 2024, IDEXX Laboratories Inc., an American diagnostics and healthcare innovation firm, introduced the Catalyst pancreatic lipase test that uses dry chemistry slide technology to accurately assess pancreatic lipase levels for diagnosing pancreatitis in dogs and cats. The test yields quick, quantitative results in less than 10 minutes and smoothly integrates with current workflows to boost diagnostic efficiency. The aim of this test is to enhance early detection and treatment of pancreatitis, a severe illness in pets. Future developments including the Catalyst SmartQC Control are expected to further refine veterinary diagnostics.
Who Are the Key Players in the Acute Pancreatitis Market?
Major companies operating in the acute pancreatitis market include:
• CalciMedica Inc.
• SCM Lifescience Co. Ltd.
• Samsung Bioepis Co Ltd.
• Global Neurotech Pharma Corporation
• Baxter International Inc.
• B. Braun Melsungen AG
• Medtronic plc
• Boston Scientific Corporation
• Fresenius Kabi AG
• Sun BioPharma Inc.
• Atox Bio Inc.
• D-Pharm Ltd.
• Regeneron Pharmaceuticals Inc.
• Merck & Co Inc
• Olympus Corporation
• Pfizer Inc.
• Ionis Pharmaceuticals Inc.
• Abbott Laboratories
• Dynavax Technologies Corporation
• GlaxoSmithKline plc
• AbbVie Inc.
• Allergan plc
• Amgen Inc.
• AstraZeneca PLC
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Novartis AG
• Sanofi SA
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
What Is The Most Dominant Region In The Acute Pancreatitis Market?
North America was the largest region in the acute pancreatitis market in 2024. The regions covered in the acute pancreatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
